Global Nucleic Acid-based Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Nucleic Acid-based Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Nucleic Acid-based Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Nucleic Acid-based Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nucleic Acid-based Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Nucleic Acid-based Drugs total market, 2019-2030, (USD Million)
Global Nucleic Acid-based Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Nucleic Acid-based Drugs total market, key domestic companies and share, (USD Million)
Global Nucleic Acid-based Drugs revenue by player and market share 2019-2024, (USD Million)
Global Nucleic Acid-based Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global Nucleic Acid-based Drugs total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Nucleic Acid-based Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics and Miragen Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nucleic Acid-based Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Nucleic Acid-based Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Nucleic Acid-based Drugs Market, Segmentation by Type
    ASO
    mRNA
    siRNA
    miRNA
    saRNA
    Aptamer

Global Nucleic Acid-based Drugs Market, Segmentation by Application
    Genetic Disease
    Cancer
    Cardiovascular Diseases
    Other

Companies Profiled:
    Ionis Pharmaceuticals
    Sarepta Therapeutics
    Nippon Shinyaku
    BioNTech
    Moderna Therapeutics
    CureVac
    Alnylam Pharmaceuticals
    Regulus Therapeutics
    Miragen Therapeutics
    Mina Therapeutics
    NeXstar Pharmaceuticals

Key Questions Answered
1. How big is the global Nucleic Acid-based Drugs market?
2. What is the demand of the global Nucleic Acid-based Drugs market?
3. What is the year over year growth of the global Nucleic Acid-based Drugs market?
4. What is the total value of the global Nucleic Acid-based Drugs market?
5. Who are the major players in the global Nucleic Acid-based Drugs market?

Table of Contents

1 Supply Summary
    1.1 Nucleic Acid-based Drugs Introduction
    1.2 World Nucleic Acid-based Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Nucleic Acid-based Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Nucleic Acid-based Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.3 China Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.4 Europe Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.5 Japan Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.6 South Korea Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.7 ASEAN Nucleic Acid-based Drugs Market Size (2019-2030)
        1.3.8 India Nucleic Acid-based Drugs Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Nucleic Acid-based Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Nucleic Acid-based Drugs Major Market Trends

2 Demand Summary
    2.1 World Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.2 World Nucleic Acid-based Drugs Consumption Value by Region
        2.2.1 World Nucleic Acid-based Drugs Consumption Value by Region (2019-2024)
        2.2.2 World Nucleic Acid-based Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.4 China Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.5 Europe Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.6 Japan Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.7 South Korea Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.8 ASEAN Nucleic Acid-based Drugs Consumption Value (2019-2030)
    2.9 India Nucleic Acid-based Drugs Consumption Value (2019-2030)

3 World Nucleic Acid-based Drugs Companies Competitive Analysis
    3.1 World Nucleic Acid-based Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Nucleic Acid-based Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Nucleic Acid-based Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for Nucleic Acid-based Drugs in 2023
    3.3 Nucleic Acid-based Drugs Company Evaluation Quadrant
    3.4 Nucleic Acid-based Drugs Market: Overall Company Footprint Analysis
        3.4.1 Nucleic Acid-based Drugs Market: Region Footprint
        3.4.2 Nucleic Acid-based Drugs Market: Company Product Type Footprint
        3.4.3 Nucleic Acid-based Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Nucleic Acid-based Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Nucleic Acid-based Drugs Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Nucleic Acid-based Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Nucleic Acid-based Drugs Consumption Value Comparison
        4.2.1 United States VS China: Nucleic Acid-based Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Nucleic Acid-based Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Nucleic Acid-based Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based Nucleic Acid-based Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024)
    4.4 China Based Companies Nucleic Acid-based Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based Nucleic Acid-based Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024)
    4.5 Rest of World Based Nucleic Acid-based Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Nucleic Acid-based Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Nucleic Acid-based Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 ASO
        5.2.2 mRNA
        5.2.3 siRNA
        5.2.4 miRNA
        5.2.5 saRNA
        5.2.6 Aptamer
    5.3 Market Segment by Type
        5.3.1 World Nucleic Acid-based Drugs Market Size by Type (2019-2024)
        5.3.2 World Nucleic Acid-based Drugs Market Size by Type (2025-2030)
        5.3.3 World Nucleic Acid-based Drugs Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Nucleic Acid-based Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Genetic Disease
        6.2.2 Cancer
        6.2.3 Cardiovascular Diseases
        6.2.4 Other
        6.2.5 Other
    6.3 Market Segment by Application
        6.3.1 World Nucleic Acid-based Drugs Market Size by Application (2019-2024)
        6.3.2 World Nucleic Acid-based Drugs Market Size by Application (2025-2030)
        6.3.3 World Nucleic Acid-based Drugs Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Ionis Pharmaceuticals
        7.1.1 Ionis Pharmaceuticals Details
        7.1.2 Ionis Pharmaceuticals Major Business
        7.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product and Services
        7.1.4 Ionis Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Ionis Pharmaceuticals Recent Developments/Updates
        7.1.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Sarepta Therapeutics
        7.2.1 Sarepta Therapeutics Details
        7.2.2 Sarepta Therapeutics Major Business
        7.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product and Services
        7.2.4 Sarepta Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Sarepta Therapeutics Recent Developments/Updates
        7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.3 Nippon Shinyaku
        7.3.1 Nippon Shinyaku Details
        7.3.2 Nippon Shinyaku Major Business
        7.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Product and Services
        7.3.4 Nippon Shinyaku Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Nippon Shinyaku Recent Developments/Updates
        7.3.6 Nippon Shinyaku Competitive Strengths & Weaknesses
    7.4 BioNTech
        7.4.1 BioNTech Details
        7.4.2 BioNTech Major Business
        7.4.3 BioNTech Nucleic Acid-based Drugs Product and Services
        7.4.4 BioNTech Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 BioNTech Recent Developments/Updates
        7.4.6 BioNTech Competitive Strengths & Weaknesses
    7.5 Moderna Therapeutics
        7.5.1 Moderna Therapeutics Details
        7.5.2 Moderna Therapeutics Major Business
        7.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Product and Services
        7.5.4 Moderna Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Moderna Therapeutics Recent Developments/Updates
        7.5.6 Moderna Therapeutics Competitive Strengths & Weaknesses
    7.6 CureVac
        7.6.1 CureVac Details
        7.6.2 CureVac Major Business
        7.6.3 CureVac Nucleic Acid-based Drugs Product and Services
        7.6.4 CureVac Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 CureVac Recent Developments/Updates
        7.6.6 CureVac Competitive Strengths & Weaknesses
    7.7 Alnylam Pharmaceuticals
        7.7.1 Alnylam Pharmaceuticals Details
        7.7.2 Alnylam Pharmaceuticals Major Business
        7.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product and Services
        7.7.4 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Alnylam Pharmaceuticals Recent Developments/Updates
        7.7.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Regulus Therapeutics
        7.8.1 Regulus Therapeutics Details
        7.8.2 Regulus Therapeutics Major Business
        7.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Product and Services
        7.8.4 Regulus Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Regulus Therapeutics Recent Developments/Updates
        7.8.6 Regulus Therapeutics Competitive Strengths & Weaknesses
    7.9 Miragen Therapeutics
        7.9.1 Miragen Therapeutics Details
        7.9.2 Miragen Therapeutics Major Business
        7.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Product and Services
        7.9.4 Miragen Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Miragen Therapeutics Recent Developments/Updates
        7.9.6 Miragen Therapeutics Competitive Strengths & Weaknesses
    7.10 Mina Therapeutics
        7.10.1 Mina Therapeutics Details
        7.10.2 Mina Therapeutics Major Business
        7.10.3 Mina Therapeutics Nucleic Acid-based Drugs Product and Services
        7.10.4 Mina Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Mina Therapeutics Recent Developments/Updates
        7.10.6 Mina Therapeutics Competitive Strengths & Weaknesses
    7.11 NeXstar Pharmaceuticals
        7.11.1 NeXstar Pharmaceuticals Details
        7.11.2 NeXstar Pharmaceuticals Major Business
        7.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product and Services
        7.11.4 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 NeXstar Pharmaceuticals Recent Developments/Updates
        7.11.6 NeXstar Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Nucleic Acid-based Drugs Industry Chain
    8.2 Nucleic Acid-based Drugs Upstream Analysis
    8.3 Nucleic Acid-based Drugs Midstream Analysis
    8.4 Nucleic Acid-based Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Nucleic Acid-based Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Nucleic Acid-based Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Nucleic Acid-based Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Nucleic Acid-based Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Nucleic Acid-based Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Nucleic Acid-based Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Nucleic Acid-based Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Nucleic Acid-based Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Nucleic Acid-based Drugs Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Nucleic Acid-based Drugs Players in 2023
    Table 12. World Nucleic Acid-based Drugs Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Nucleic Acid-based Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Nucleic Acid-based Drugs Player
    Table 15. Nucleic Acid-based Drugs Market: Company Product Type Footprint
    Table 16. Nucleic Acid-based Drugs Market: Company Product Application Footprint
    Table 17. Nucleic Acid-based Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Nucleic Acid-based Drugs Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Nucleic Acid-based Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Nucleic Acid-based Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Nucleic Acid-based Drugs Revenue Market Share (2019-2024)
    Table 23. China Based Nucleic Acid-based Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Nucleic Acid-based Drugs Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Nucleic Acid-based Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Nucleic Acid-based Drugs Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Nucleic Acid-based Drugs Revenue Market Share (2019-2024)
    Table 29. World Nucleic Acid-based Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Nucleic Acid-based Drugs Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Nucleic Acid-based Drugs Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Nucleic Acid-based Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Nucleic Acid-based Drugs Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Nucleic Acid-based Drugs Market Size by Application (2025-2030) & (USD Million)
    Table 35. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
    Table 36. Ionis Pharmaceuticals Major Business
    Table 37. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product and Services
    Table 38. Ionis Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Ionis Pharmaceuticals Recent Developments/Updates
    Table 40. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 42. Sarepta Therapeutics Major Business
    Table 43. Sarepta Therapeutics Nucleic Acid-based Drugs Product and Services
    Table 44. Sarepta Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Sarepta Therapeutics Recent Developments/Updates
    Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 47. Nippon Shinyaku Basic Information, Area Served and Competitors
    Table 48. Nippon Shinyaku Major Business
    Table 49. Nippon Shinyaku Nucleic Acid-based Drugs Product and Services
    Table 50. Nippon Shinyaku Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Nippon Shinyaku Recent Developments/Updates
    Table 52. Nippon Shinyaku Competitive Strengths & Weaknesses
    Table 53. BioNTech Basic Information, Area Served and Competitors
    Table 54. BioNTech Major Business
    Table 55. BioNTech Nucleic Acid-based Drugs Product and Services
    Table 56. BioNTech Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. BioNTech Recent Developments/Updates
    Table 58. BioNTech Competitive Strengths & Weaknesses
    Table 59. Moderna Therapeutics Basic Information, Area Served and Competitors
    Table 60. Moderna Therapeutics Major Business
    Table 61. Moderna Therapeutics Nucleic Acid-based Drugs Product and Services
    Table 62. Moderna Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Moderna Therapeutics Recent Developments/Updates
    Table 64. Moderna Therapeutics Competitive Strengths & Weaknesses
    Table 65. CureVac Basic Information, Area Served and Competitors
    Table 66. CureVac Major Business
    Table 67. CureVac Nucleic Acid-based Drugs Product and Services
    Table 68. CureVac Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. CureVac Recent Developments/Updates
    Table 70. CureVac Competitive Strengths & Weaknesses
    Table 71. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
    Table 72. Alnylam Pharmaceuticals Major Business
    Table 73. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product and Services
    Table 74. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Alnylam Pharmaceuticals Recent Developments/Updates
    Table 76. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    Table 77. Regulus Therapeutics Basic Information, Area Served and Competitors
    Table 78. Regulus Therapeutics Major Business
    Table 79. Regulus Therapeutics Nucleic Acid-based Drugs Product and Services
    Table 80. Regulus Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Regulus Therapeutics Recent Developments/Updates
    Table 82. Regulus Therapeutics Competitive Strengths & Weaknesses
    Table 83. Miragen Therapeutics Basic Information, Area Served and Competitors
    Table 84. Miragen Therapeutics Major Business
    Table 85. Miragen Therapeutics Nucleic Acid-based Drugs Product and Services
    Table 86. Miragen Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Miragen Therapeutics Recent Developments/Updates
    Table 88. Miragen Therapeutics Competitive Strengths & Weaknesses
    Table 89. Mina Therapeutics Basic Information, Area Served and Competitors
    Table 90. Mina Therapeutics Major Business
    Table 91. Mina Therapeutics Nucleic Acid-based Drugs Product and Services
    Table 92. Mina Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Mina Therapeutics Recent Developments/Updates
    Table 94. NeXstar Pharmaceuticals Basic Information, Area Served and Competitors
    Table 95. NeXstar Pharmaceuticals Major Business
    Table 96. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product and Services
    Table 97. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 98. Global Key Players of Nucleic Acid-based Drugs Upstream (Raw Materials)
    Table 99. Nucleic Acid-based Drugs Typical Customers
List of Figure
    Figure 1. Nucleic Acid-based Drugs Picture
    Figure 2. World Nucleic Acid-based Drugs Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Nucleic Acid-based Drugs Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Nucleic Acid-based Drugs Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Nucleic Acid-based Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Nucleic Acid-based Drugs Revenue (2019-2030) & (USD Million)
    Figure 13. Nucleic Acid-based Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Nucleic Acid-based Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Nucleic Acid-based Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Nucleic Acid-based Drugs by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Nucleic Acid-based Drugs Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Nucleic Acid-based Drugs Markets in 2023
    Figure 27. United States VS China: Nucleic Acid-based Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Nucleic Acid-based Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Nucleic Acid-based Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Nucleic Acid-based Drugs Market Size Market Share by Type in 2023
    Figure 31. ASO
    Figure 32. mRNA
    Figure 33. siRNA
    Figure 34. miRNA
    Figure 35. saRNA
    Figure 36. Aptamer
    Figure 37. World Nucleic Acid-based Drugs Market Size Market Share by Type (2019-2030)
    Figure 38. World Nucleic Acid-based Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 39. World Nucleic Acid-based Drugs Market Size Market Share by Application in 2023
    Figure 40. Genetic Disease
    Figure 41. Cancer
    Figure 42. Cardiovascular Diseases
    Figure 43. Other
    Figure 44. Nucleic Acid-based Drugs Industrial Chain
    Figure 45. Methodology
    Figure 46. Research Process and Data Source

Companies Mentioned

Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals